Mead Johnson Nutrition (MJN)
The stock has been boosted by its role as a conservative consumer-staples play and, more recently, China’s shift on its one-child policy. Earnings estimates are rising, but it should be noted that MJN still has to rise about 5% to get to its breakout level. Also, it’s no longer cheap at 23 times forward earnings. Keep an eye on this one, but tread carefully.
The charts of two ADRs also stand out from the crowd, one for its positive technical setup and another for its flashing caution signal.